Article
A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling.
European addiction research - 1 Jan 2016
Kovanen Leena, Basnet Syaron, Castrén Sari, Pankakoski Maiju, Saarikoski Sirkku T, Partonen Timo, Alho Hannu, Lahti Tuuli
Abstract excerpt
BACKGROUND/AIMS: Effective treatment strategies are needed for the treatment of pathological gambling (PG). The efficacy of as-needed naltrexone was assessed in a single-centre, randomised, double-blind, placebo-controlled trial. METHODS: The participants (n = 101) received either as-needed placebo or naltrexone (50 mg) and psychosocial support for 20 weeks. The primary outcome measure was the severity of PG...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.